BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33786805)

  • 1. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
    Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis.
    Mohajeri MH; Figlewicz DA; Bohn MC
    Hum Gene Ther; 1999 Jul; 10(11):1853-66. PubMed ID: 10446925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Verdés S; Ariza L; Sánchez-Brualla I; Brocard F; Bosch A; Navarro X; Herrando-Grabulosa M
    Neurotherapeutics; 2020 Jul; 17(3):1048-1060. PubMed ID: 31965551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice.
    Guillot S; Azzouz M; Déglon N; Zurn A; Aebischer P
    Neurobiol Dis; 2004 Jun; 16(1):139-49. PubMed ID: 15207271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
    Suzuki M; Svendsen CN
    Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
    Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
    Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
    Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
    Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
    Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Setoguchi Y; Abe K
    Apoptosis; 2002 Aug; 7(4):329-34. PubMed ID: 12101392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF delivery using human neural progenitor cells in a rat model of ALS.
    Klein SM; Behrstock S; McHugh J; Hoffmann K; Wallace K; Suzuki M; Aebischer P; Svendsen CN
    Hum Gene Ther; 2005 Apr; 16(4):509-21. PubMed ID: 15871682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1
    Mòdol-Caballero G; Herrando-Grabulosa M; García-Lareu B; Solanes N; Verdés S; Osta R; Francos-Quijorna I; López-Vales R; Calvo AC; Bosch A; Navarro X
    Neurobiol Dis; 2020 Apr; 137():104793. PubMed ID: 32032731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.
    Krakora D; Mulcrone P; Meyer M; Lewis C; Bernau K; Gowing G; Zimprich C; Aebischer P; Svendsen CN; Suzuki M
    Mol Ther; 2013 Aug; 21(8):1602-10. PubMed ID: 23712039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve-muscle contacts.
    Sharp PS; Tyreman N; Jones KE; Gordon T
    Neurobiol Dis; 2018 May; 113():33-44. PubMed ID: 29409912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.